Clozapine treatment of persistent paroxysmal dyskinesia associated with concomitant paroxetine and sumatriptan use

被引:5
作者
Abraham, JT
Brown, R
Meltzer, HY
机构
[1] BROWN UNIV,DEPT CHILD & FAMILY PSYCHIAT,PROVIDENCE,RI 02912
[2] COLUMBIA UNIV,DEPT PSYCHIAT,NEW YORK,NY
[3] VANDERBILT UNIV,SCH MED,DEPT PSYCHIAT,LAB BIOL PSYCHIAT,NASHVILLE,TN 37212
关键词
bipolar disorder; clozapine; paroxetine; paroxysmal dyskinesia; sumatriptan;
D O I
10.1016/S0006-3223(97)00248-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
[No abstract available]
引用
收藏
页码:144 / 146
页数:3
相关论文
共 36 条
[1]  
AZMITIA EC, 1978, HDB PSYCHOPHARMACOLO, V9, P233
[2]  
BACHER NM, 1991, AM J PSYCHIAT, V148, P274
[3]   FLUOXETINE, FLUVOXAMINE AND EXTRAPYRAMIDAL TRACT DISORDERS [J].
BALDWIN, D ;
FINEBERG, N ;
MONTGOMERY, S .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1991, 6 (01) :51-58
[4]  
BLACK B, 1992, J CLIN PSYCHIAT, V53, P327
[5]   THE SAFETY OF CONCOMITANT USE OF SUMATRIPTAN AND ANTIDEPRESSANT TREATMENTS [J].
BLIER, P ;
BERGERON, R .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (02) :106-109
[6]  
BLIER P, 1990, J CLIN PSYCHIAT, V51, P14
[7]  
BOUCHARD RH, 1989, AM J PSYCHIAT, V146, P1352
[8]  
BUDMAN CL, 1991, AM J PSYCHIAT, V148, P1403
[9]  
CASEY DE, 1983, ANN INTERN MED, V98, P673, DOI 10.7326/0003-4819-98-5-673_3
[10]   CEREBRAL DOPAMINE FUNCTION IN RATS FOLLOWING WITHDRAWAL FROM ONE YEAR OF CONTINUOUS NEUROLEPTIC ADMINISTRATION [J].
CLOW, A ;
THEODOROU, A ;
JENNER, P ;
MARSDEN, CD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1980, 63 (2-3) :145-157